期刊文献+

生长抑制因子4在子宫内膜癌中的表达及意义 被引量:3

Expression of inhibitor of growth family member 4 in endometrial cancer and its significance
原文传递
导出
摘要 目的:检测生长抑制因子4(ING4)基因在不同子宫内膜癌中的表达情况,并探讨其表达与子宫内膜癌发生、发展及预后的关系。方法:采用RT-PCR方法和免疫组化S-P法检测25份正常的增生期子宫内膜、15份不典型增生的子宫内膜及45份子宫内膜癌组织中ING4的表达情况,观察结果并进行统计学处理。结果:免疫组化结果显示,ING4在增生子宫内膜中表达最多,在不典型增生的子宫内膜组织中的表达显著低于增生子宫内膜,在子宫内膜癌组织中的表达显著低于不典型增生组织,3组比较,差异有统计学意义(P<0.05)。RT-PCR结果与免疫组化测定结果一致,ING4 mRNA的表达在增生期子宫内膜组织、不典型增生子宫内膜组织、子宫内膜癌组织中逐渐降低,3组比较,差异有统计学意义(P<0.05)。在子宫内膜癌组织中,ING4的表达与组织学分级显著相关(P<0.05),与肌层浸润深度、淋巴结转移无关(P>0.05),但其表达与组织病理学分期的关系尚需进一步研究。结论:ING4在子宫内膜癌和不典型增生组织中的表达有不同程度的丢失,ING4的低表达促进了肿瘤的发生。检测ING4可能成为子宫内膜癌早期诊断及预测癌前病变的重要指标之一。 Objective: To detect the expressions of inhibitor of growth family member 4 (ING4) in different endometfial lesions, explore the relationship between ING4 and oneogenesis, development and prognosis of endometrial cancer. Methods: RT-PCR and immu- nohistochemical SP method were used to detect the expressions of ING4 in 25 cases with normal endometrium during the proliferative phase, 15 cases with endometrium of atypical hyperplasia, and 45 cases with endometrial cancer, the results were observed and analyzed statistical- The results of immunohistochemical SP method showed that the expression level of INGA in normal endometrium during the pro-liferative phase was the highest, the expression level of ING4 in endometrium of atypical hyperplasia was significantly lower than that in normal endometrium during the proliferative phase, and the expression level of ING4 in endometrial cancer was significantly lower than that in endometrium of atypical hyperplasia, there was statistieally signifieant difference among the three groups (P〈0. 05 ) . The results of RT- PCR and immunohistochemical SP method were the same, the expression level of ING4 mRNA in normal endometrium during the proliferative phase, endometrium of atypical hyperplasia, and endometrial cancer decreased gradually, there was statistically significant difference among the three groups (P〈0. 05 ) . In endometrial cancer, the expression level of ING4 was significantly correlated with histological grading (P〈 0. 05 ), and it was not correlated with the depth of myometrial invasion and lymph node metastasis (P〉0.05), the relationship between the expression level of ING4 and histopathological staging needed further studies. Conclusion: The expression levels of ING4 in endometrial cancer and endometrium of atypical hyperplasia are low to a certain degree, which promote the oncogenesis of endometrial cancer, ING4 may become to be an important index for early diagnosis of endometrial cancer and prediction of cervical precancerous lesion.
出处 《中国妇幼保健》 CAS 2015年第15期2414-2417,共4页 Maternal and Child Health Care of China
关键词 生长抑制因子4 子宫内膜癌 免疫组化 Inhibitor of growth family member 4 Endometrial cancer Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献24

  • 1Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59: 225-249.
  • 2Miller DS, King LP. Gynecologic oncology group trials in uterine corpus malignancies: recent progress. J Gynecol Oncol 2008, 19: 218-222.
  • 3Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol 2003, 21: 4214-4221.
  • 4Mariani A, Webb M J, Keeney GL, Lesnick TG, Podratz KC. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Onco12002, 87: 274-280.
  • 5Creasman WT, Soper JT, McCarty K J, McCarty KS, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 1985, 151: 922-932.
  • 6Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M, et al. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecol Oncol 2005, 98: 383-389.
  • 7Suthipintawong C, Wejaranayang C, Vipupinyo C. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. J Med Assoc Thai 2008, 91: 1779-1784.
  • 8Markova I, Duskova M, Lubusky M, Kudela M, Zapletalova J, Prochazka M, et al. Selected immunohistochemical progvostic factors in endometrial cancer. Int J GynecolCancer 2010, 20: 576-582.
  • 9Lee E J, Kim T J, Kim DS, Choi CH, Lee JW, Lee JH, et al. p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review. Gynecol Onco12010, 116: 533-538.
  • 10Lee YK, Park NH. Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers. Gynecol Onco12009, 112: 475-480.

共引文献7

同被引文献9

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部